High serum vitamin B12 binding capacity as a marker of the fibrolamellar variant of hepatocellular carcinoma.

@article{Paradinas1982HighSV,
  title={High serum vitamin B12 binding capacity as a marker of the fibrolamellar variant of hepatocellular carcinoma.},
  author={Fernando J Paradinas and W. M. Melia and Mark L Wilkinson and Bernard C. Portmann and Philip James Johnson and Iain M. Murray-Lyon and Roger Williams},
  journal={British medical journal},
  year={1982},
  volume={285 6345},
  pages={840-2}
}
Ten (9.3%) of 107 patients with hepatocellular carcinoma had considerably increased serum unsaturated vitamin B12 binding capacity. All 10 were young (mean 12 years), had no serum alpha-fetoprotein, and no underlying cirrhosis; all had a longer survival compared with patients without increased serum unsaturated vitamin B12 binding capacity in the study. Seven of the 10 patients had fibrolamellar hepatocellular carcinoma, a recently recognised histological variant, which was found in only one… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 26 extracted citations

Similar Papers

Loading similar papers…